Assembly Biosciences (ASMB) Capital Expenditures Growth (1y) (2013 - 2024)
Assembly Biosciences (ASMB) Capital Expenditures Growth (1y) (2013 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Assembly Biosciences |
418.96 Mn |
192.36 Mn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2024 |
-70.83% |
| Sep 30, 2023 |
33.33% |
| Mar 31, 2021 |
4,635.38% |
| Jun 30, 2020 |
694.12% |
| Mar 31, 2020 |
-95.63% |
| Dec 31, 2019 |
-92.89% |
| Jun 30, 2019 |
-3.77% |
| Mar 31, 2019 |
3,715.38% |
| Dec 31, 2018 |
-41.69% |
| Sep 30, 2018 |
-92.65% |
| Dec 31, 2017 |
223.38% |
| Sep 30, 2017 |
1,427.79% |
| Dec 31, 2016 |
989.64% |
| Mar 31, 2016 |
-92.96% |
| Dec 31, 2015 |
-92.07% |
| Mar 31, 2015 |
1,086.21% |
| Dec 31, 2014 |
9,773.15% |
| Dec 31, 2013 |
131,000.00% |
